ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ACHV vs TKNO // PIOTROSKI F-SCORE QUALITY

Achieve Life Sciences Inc. (NASDAQ) VS. Alpha Teknova Inc. (NASDAQ) • 15-METRIC TALLY: ACHV 1 — TKNO 4
▲ PIOTROSKI F-SCORE QUALITY LEADER: TKNO
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACHV VS. TKNO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ACHV TKNO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 33.20% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -21.30% -13.70 TKNO /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -6.69% -1.96% -4.73 TKNO /fcf-yield <GO>
Operating Margin — -41.90% — TIE /operating-margins <GO>
Net Profit Margin — -42.60% — TIE /net-margins <GO>
Revenue Growth (YoY) — 7.40% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 6.93 — TIE /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 2/9 5/9 -3.00 TKNO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 53.2 54.6 -1.40 TKNO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $739.9M $499.2M $240.7M ACHV /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ACHV REV TKNO REV ACHV GROSS % TKNO GROSS % ACHV FCF TKNO FCF
FY 2025 $0 $40.5M — 33.2% -$49.5M -$9.8M
FY 2024 $0 $37.7M — 19.2% -$29.8M -$13.5M
FY 2023 $0 $36.7M — — -$24.5M -$18.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACHV // BETA —
TKNO // BETA —